MoneyWorks4Me

Hester Biosciences informs about transcript of conference call

18 May 2026 Evaluate

Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that it attached the transcript of the earnings conference call held by the management of the Company with all investors on Friday, 15 May 2026 at 2:00 pm (IST) to discuss the financial results for the for the quarter and year ended 31 March 2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1850.20
Dr. Reddys Labs. 1210.65
Cipla 1374.50
Lupin 2095.55
Zydus Lifesciences 1162.00
View more..